Accolate and Quincke's disease - a phase IV clinical study of FDA data
Quincke's disease is reported only by a few people who take Accolate.
The phase IV clinical study analyzes which people take Accolate and have Quincke's disease. It is created by eHealthMe based on reports of 4,078 people who have side effects while taking Accolate from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
4,078 people reported to have side effects when taking Accolate.
Among them, 1 person (0.02%) has Quincke's disease.
What is Accolate?
Accolate has active ingredients of zafirlukast. It is often used in asthma. eHealthMe is studying from 4,153 Accolate users for its effectiveness, alternative drugs and more.
What is Quincke's disease?
Quincke's disease (a form of localized swelling of the deeper layers of the skin and fatty tissues beneath the skin) is found to be associated with 949 drugs and 468 conditions by eHealthMe.
Number of Accolate and Quincke's disease reports submitted per year:
Gender of people who have Quincke's disease when taking Accolate *:
- female: 100 %
- male: 0.0 %
Age of people who have Quincke's disease when taking Accolate *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 100 %
- 50-59: 0.0 %
- 60+: 0.0 %
Common drugs people take besides Accolate *:
- Zofran: 1 person, 100.00%
- Zantac: 1 person, 100.00%
- Xopenex Hfa: 1 person, 100.00%
- Proair Hfa: 1 person, 100.00%
- Miralax: 1 person, 100.00%
- Lexapro: 1 person, 100.00%
- Kalbitor: 1 person, 100.00%
- Gastrocrom: 1 person, 100.00%
- Epipen: 1 person, 100.00%
- Benadryl: 1 person, 100.00%
Common side effects people have besides Quincke's disease *:
- Tearfulness (excess tearing): 1 person, 100.00%
- Stress And Anxiety: 1 person, 100.00%
- Panic Disorder: 1 person, 100.00%
- Discomfort: 1 person, 100.00%
- Chest Pain: 1 person, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take Accolate and have Quincke's disease?Check whether Quincke's disease is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Quincke's disease and when was it recovered:
Expand to all the drugs that have ingredients of zafirlukast:
Alternative drugs to, pros and cons of Accolate:
- Accolate (4,153 reports)
Common Accolate side effects:
- Asthma: 498 reports
- Breathing difficulty: 354 reports
- Chest pain: 305 reports
- Fatigue (feeling of tiredness): 276 reports
- Drug ineffective: 267 reports
- Headache (pain in head): 261 reports
- Weakness: 225 reports
Browse all side effects of Accolate:a b c d e f g h i j k l m n o p q r s t u v w x y z
Quincke's disease treatments and more:
- Quincke's disease (16,202 reports)
COVID vaccines that are related to Quincke's disease:
- Quincke's disease in Moderna COVID Vaccine
- Quincke's disease in Pfizer BioNTech Covid Vaccine
- Quincke's disease in Johnson and Johnson Covid Vaccine
Common drugs associated with Quincke's disease:
- Firazyr: 1,985 reports
- Kalbitor: 787 reports
- Heparin: 440 reports
- Hydramine: 413 reports
- Epipen: 379 reports
- Diphen: 348 reports
- Zyrtec: 273 reports
- Benadryl: 260 reports
- Zofran: 244 reports
- Vitamin d: 217 reports
All the drugs that are associated with Quincke's disease:
- Quincke's disease (949 drugs)
Common conditions associated with Quincke's disease:
All the conditions that are associated with Quincke's disease:
- Quincke's disease (468 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on zafirlukast (the active ingredients of Accolate) and Accolate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Klor-Con and Kadian drug interaction - 5 seconds ago
- Depakene and Nervous System Disorder - 6 seconds ago
- Cardizem Cd and Product Solubility Abnormal - 8 seconds ago
- Bc and Klonopin drug interaction - 12 seconds ago
- Dificid and Blood Lactic Acid Increased - 14 seconds ago
- Mivacron and Rashes - 16 seconds ago
- Emgality and Wellbutrin Sr drug interaction - 20 seconds ago
- High Blood Cholesterol and Tooth Extraction - 24 seconds ago
- Lisinopril and Rhythm Idioventricular - 26 seconds ago
- Antivert and Diarrhea Aggravated - 36 seconds ago